|
Market Analysis Reports of Gacyclidine
|
Global Market Report of Gacyclidine (CAS 68134-81-6) December 2024
Otonomy Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... N-Methyl-D-Aspartate (NMDA) receptor antagonist gacyclidine in development for the treatment of tinnitus ...
Tinnitus - Pipeline Insight, 2021 ... OTO-313 is a sustained-exposure formulation of gacyclidine, a potent and selective NMDA receptor ... formulation technology to provide several weeks of gacyclidine drug exposure in the inner ear ...
Tinnitus - Pipeline Review, H2 2020 Tinnitus - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tinnitus - Pipeline Review, H2 2020, provides an overview of the Tinnitus (Ear Nose Throat Disorders) pipeline landscape. ...
Tinnitus (Ear Nose Throat Disorders) - Drugs In Development, 2021 Tinnitus (Ear Nose Throat Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tinnitus - Drugs In Development, 2021, provides an overview of the Tinnitus (Ear Nose Throat ...
|
|
|